aTyr Pharma, Inc.
ATYR
$0.53
-$0.03-5.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -70.03M | -74.12M | -75.12M | -66.64M | -63.41M |
| Total Depreciation and Amortization | 1.56M | 1.55M | 1.16M | 1.16M | 1.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.52M | 3.13M | 2.51M | 1.86M | 1.00M |
| Change in Net Operating Assets | 5.86M | 7.45M | 8.53M | 8.02M | -903.00K |
| Cash from Operations | -59.08M | -61.99M | -62.92M | -55.60M | -62.16M |
| Capital Expenditure | -215.00K | -77.00K | -71.00K | -49.00K | -48.00K |
| Sale of Property, Plant, and Equipment | 12.00K | 12.00K | 7.00K | 7.00K | 7.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.06M | -4.99M | -27.52M | 10.78M | 14.21M |
| Cash from Investing | 10.86M | -5.05M | -27.58M | 10.74M | 14.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -550.00K | -539.00K | -528.00K | -517.00K | -507.00K |
| Issuance of Common Stock | 47.79M | 66.55M | 85.51M | 55.78M | 51.27M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 47.24M | 66.01M | 84.98M | 55.26M | 50.76M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -981.00K | -1.03M | -5.52M | 10.40M | 2.77M |